{"id":78434,"date":"2015-09-18T05:39:58","date_gmt":"2015-09-18T09:39:58","guid":{"rendered":"http:\/\/countingpips.com\/?p=78434"},"modified":"2015-09-18T07:20:05","modified_gmt":"2015-09-18T11:20:05","slug":"google-takes-on-americas-big-health-crisis","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/forex\/2015\/09\/google-takes-on-americas-big-health-crisis\/","title":{"rendered":"Google Takes on America\u2019s Big Health Crisis"},"content":{"rendered":"
September 18, 2015<\/div>
\r\n<\/div><\/div>

By WallStreetDaily.com<\/u><\/a> \"Diabetes<\/p>\n

By Samantha Solomon<\/a>, Editor-in-Chief, Commodities<\/em><\/p>\n

Google<\/strong> (GOOGL<\/a>), that amazing innovator, is turning its well-funded and creative energy on diabetes \u2013 one of the country\u2019s most prevalent health issues<\/a>.<\/p>\n

The disease is the first major target of Google\u2019s Life Sciences division. It might sound out of place for Google to enter the medical field, but the company\u2019s penchant for organizing and analyzing data would be highly useful for diabetics.<\/p>\n

Living with the disease is all about managing your blood glucose numbers, which are influenced by things like diet, exercise, metabolism, time of day, etc.<\/p>\n

\u201cUnlike a migraine or acne, diabetes management is all about developing an understanding and manipulation of numbers over time. Diabetes is very quantitative,\u201d said Cyrus Khambatta in an NPR interview. Khambatta has Type 1 diabetes and works as a nutritionist.<\/p>

\r\n
\r\n

Free Reports:<\/p><\/div>\r\n

\r\n

<\/a>\r\n\t Get Our Free Metatrader 4 Indicators<\/u><\/b><\/a> - Put Our Free MetaTrader 4 Custom Indicators on your charts when you join our Weekly Newsletter<\/p>

\r\n
\r\n
\r\n

<\/a>\r\n\t Get our Weekly Commitment of Traders Reports<\/u><\/b><\/a> - See where the biggest traders (Hedge Funds and Commercial Hedgers) are positioned in the futures markets on a weekly basis.<\/p>

\r\n<\/div>\r\n

\r\n
<\/div>\n

This is also a very lucrative time for Google to break into this field. NPR reported that the total cost of managing diabetes was $245 billion just in the United States. Socially, we\u2019re also much more open to wearable technology and gathering personal data about ourselves, like with a Fitbit.<\/p>\n

One of Google\u2019s first emerging products is a contact lens with a tiny sensor embedded in it that can measure blood glucose levels using tears.<\/p>\n

This is appealing to diabetics because it eliminates the pain and process of checking glucose levels using blood obtained from a pinprick. It\u2019s also more discrete than wearing an insulin pump and sensor, which looks like a beeper with thin tubing that connects to a needle in the abdomen.<\/p>\n

Another Letter in the Alphabet<\/h2>\n

This undertaking aligns the company\u2019s shoot-for-the-moon attitude, a la self-driving cars and stratospheric internet balloons.<\/p>\n

Google\u2019s Life Sciences division is a spinoff of the company\u2019s secretive research arm, Google X. The division will sit under the organization\u2019s new umbrella company, Alphabet.<\/p>\n

The division has already announced partnerships with several medical companies, including Sanofi <\/strong>(SNY<\/a>), which makes an insulin inhaler and several other diabetes management products, Johnson & Johnson<\/strong> (JNJ<\/a>), Biogen Inc.<\/strong> (BIIB<\/a>), Novartis AG<\/strong> (NVS<\/a>), and DexCom, Inc.<\/strong> (DXCM<\/a>).<\/p>\n

Good investing,<\/p>\n

Samantha Solomon<\/p>\n

The post Google Takes on America\u2019s Big Health Crisis<\/a> appeared first on Wall Street Daily<\/a>.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

By WallStreetDaily.com By Samantha Solomon, Editor-in-Chief, Commodities Google (GOOGL), that amazing innovator, is turning its well-funded and creative energy on diabetes \u2013 one of the country\u2019s most prevalent health issues. The disease is the first major target of Google\u2019s Life Sciences division. It might sound out of place for Google to enter the medical field, […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-78434","post","type-post","status-publish","format-standard","hentry","no-post-thumbnail"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts\/78434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/comments?post=78434"}],"version-history":[{"count":2,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts\/78434\/revisions"}],"predecessor-version":[{"id":78448,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts\/78434\/revisions\/78448"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/media?parent=78434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/categories?post=78434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/tags?post=78434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}